Short Disease Duration Does Not Always Indicate Early Crohn's Disease

Affiliations

¹ Gastroenterology Department, Hospital de Galdakao, Vizcaya, Spain.
² Gastroenterology Department, Hospital Clínico Universitario de Santiago de Compostela, A Coruña, Spain.

Comment

Iago Rodríguez-Lago et al. Clin Gastroenterol Hepatol. 2019 Jul.

. 2019 Jul;17(8):1646.

doi: 10.1016/j.cgh.2019.01.017. Epub 2019 Jan 18.

¹ Gastroenterology Department, Hospital de Galdakao, Vizcaya, Spain.
² Gastroenterology Department, Hospital Clínico Universitario de Santiago de Compostela, A Coruña, Spain.

No abstract available

Comment in

Reply.
Faleck D, Dulai P, Ungaro R. Faleck D, et al. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1646-1647. doi: 10.1016/j.cgh.2019.02.003. Epub 2019 Feb 13. Clin Gastroenterol Hepatol. 2019. PMID: 30771499 No abstract available.

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Faleck DM, Winters A, Chablaney S, Shashi P, Meserve J, Weiss A, Aniwan S, Koliani-Pace JL, Kochhar G, Boland BS, Singh S, Hirten R, Shmidt E, Kesar V, Lasch K, Luo M, Bohm M, Varma S, Fischer M, Hudesman D, Chang S, Lukin D, Sultan K, Swaminath A, Gupta N, Siegel CA, Shen B, Sandborn WJ, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Dulai PS, Ungaro R. Faleck DM, et al. Clin Gastroenterol Hepatol. 2019 Nov;17(12):2497-2505.e1. doi: 10.1016/j.cgh.2018.12.040. Epub 2019 Jan 6. Clin Gastroenterol Hepatol. 2019. PMID: 30625408 Free PMC article.